Free Trial

Veru (VERU) Competitors

Veru logo
$4.07 -0.22 (-5.02%)
As of 10:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VERU vs. MED, EL, IPAR, PBH, HLF, NUS, USNA, NATR, UTMD, and FTLF

Should you be buying Veru stock or one of its competitors? The main competitors of Veru include MEDIFAST (MED), Estee Lauder Companies (EL), Interparfums (IPAR), Prestige Consumer Healthcare (PBH), Herbalife (HLF), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Utah Medical Products (UTMD), and FitLife Brands (FTLF).

Veru vs. Its Competitors

Veru (NASDAQ:VERU) and MEDIFAST (NYSE:MED) are both small-cap personal products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

Veru currently has a consensus target price of $33.33, suggesting a potential upside of 720.01%. MEDIFAST has a consensus target price of $16.50, suggesting a potential upside of 18.36%. Given Veru's stronger consensus rating and higher probable upside, equities analysts plainly believe Veru is more favorable than MEDIFAST.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veru
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
MEDIFAST
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

MEDIFAST has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than MEDIFAST, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veru$16.89M3.53-$37.80M-$2.20-1.85
MEDIFAST$602.46M0.25$2.09M$0.3243.56

MEDIFAST has a net margin of 0.76% compared to Veru's net margin of 0.00%. MEDIFAST's return on equity of 2.00% beat Veru's return on equity.

Company Net Margins Return on Equity Return on Assets
VeruN/A -143.24% -85.22%
MEDIFAST 0.76%2.00%1.50%

Veru has a beta of -0.75, suggesting that its share price is 175% less volatile than the S&P 500. Comparatively, MEDIFAST has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500.

In the previous week, Veru had 1 more articles in the media than MEDIFAST. MarketBeat recorded 4 mentions for Veru and 3 mentions for MEDIFAST. MEDIFAST's average media sentiment score of 0.19 beat Veru's score of 0.15 indicating that MEDIFAST is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veru
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
MEDIFAST
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

47.2% of Veru shares are owned by institutional investors. Comparatively, 95.5% of MEDIFAST shares are owned by institutional investors. 15.2% of Veru shares are owned by company insiders. Comparatively, 2.9% of MEDIFAST shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

MEDIFAST beats Veru on 10 of the 16 factors compared between the two stocks.

Get Veru News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERU vs. The Competition

MetricVeruMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$59.74M$10.57B$6.12B$10.64B
Dividend YieldN/A1.87%5.66%4.69%
P/E Ratio-1.8521.0886.1127.75
Price / Sales3.5327.35588.17183.92
Price / CashN/A25.3838.3262.20
Price / Book1.843.4412.976.80
Net Income-$37.80M$208.83M$3.30B$275.97M
7 Day Performance6.97%0.35%3.27%2.08%
1 Month Performance5.31%3.37%10.12%9.09%
1 Year Performance-50.74%-3.99%83.41%36.72%

Veru Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERU
Veru
2.3762 of 5 stars
$4.07
-5.0%
$33.33
+720.0%
-53.0%$59.74M$16.89M-1.85230Analyst Forecast
MED
MEDIFAST
3.1157 of 5 stars
$13.85
+1.0%
$16.50
+19.1%
-21.4%$150.69M$602.46M36.08870Analyst Forecast
EL
Estee Lauder Companies
3.8162 of 5 stars
$89.17
+2.9%
$88.55
-0.7%
+0.3%$31.19B$14.33B57.7757,000Positive News
Analyst Forecast
High Trading Volume
IPAR
Interparfums
4.1602 of 5 stars
$100.24
-1.0%
$162.00
+61.6%
-23.6%$3.25B$1.45B20.01530Positive News
Analyst Forecast
PBH
Prestige Consumer Healthcare
4.3519 of 5 stars
$61.95
-1.6%
$94.80
+53.0%
-8.2%$3.10B$1.14B13.75540
HLF
Herbalife
4.0298 of 5 stars
$8.53
-3.9%
$11.50
+34.9%
+26.6%$914.55M$4.99B4.208,600Analyst Forecast
NUS
Nu Skin Enterprises
3.4225 of 5 stars
$12.09
-1.3%
$6.88
-43.1%
+81.7%$605.85M$1.73B10.123,100Positive News
Analyst Forecast
USNA
USANA Health Sciences
4.6998 of 5 stars
$27.70
-2.9%
$36.00
+30.0%
-25.9%$521.29M$854.50M10.691,700News Coverage
Analyst Forecast
Gap Down
NATR
Nature's Sunshine Products
3.7354 of 5 stars
$15.21
-4.3%
$20.50
+34.8%
+11.0%$280.23M$454.36M18.26850News Coverage
Positive News
Analyst Forecast
UTMD
Utah Medical Products
2.325 of 5 stars
$62.72
-0.1%
N/A-4.2%$201.35M$40.90M16.79180News Coverage
Analyst Forecast
FTLF
FitLife Brands
3.8665 of 5 stars
$19.91
+0.2%
$23.00
+15.5%
+25.7%$186.70M$64.47M0.0020News Coverage
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:VERU) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners